Maternal thyroid function test level during the first trimester of pregnancy at a center Yazd, Iran: A cross-sectional study


Background: Thyroid dysfunction is associated with negative pregnancy outcomes. There is a lack of reliable information on thyroid hormones in Iranian pregnant women, especially in Yazd.

Objective: To determine the safe thyroid hormone levels in women of Yazd and also the first trimester-specific reference ranges for serum thyroid-stimulating hormone (TSH), thyroxine (T4), and triiodothyronine (T3).

Materials and Methods: In this cross-sectional study, the serum of 1,148 women in the first trimester of pregnancy was analyzed. Thyroid function tests (TSH, T4, T3) were measured through radioimmunoassay (RIA) [immunoradiometric (IRMA) for TSH]. The study was conducted in Yazd, from September 2018 to November 2019. Reference intervals were defined as the 5th, 50th, and 95th percentiles.

Results: The mean age of the participants was 28.78 (± 5.86 yr) (range: 15-45 yr). The thyroid hormones reference intervals in the first trimester were TSH (0.2-3.8 mIU/l), T4 (7.45-12.75, μg/dl), and T3 (100-217 ng/dl).

Conclusion: The results of the present study determined a local thyroid function measurement in the first trimester of pregnancy at a center of Yazd, Iran. This could facilitate the decision-making of maternal TSH level during the first trimester of pregnancy.

Key words: First pregnancy trimester, Thyrotropin, Thyroxine, Triiodothyronine.

[1] Alemu A, Terefe B, Abebe M, Biadgo B. Thyroid hormone dysfunction during pregnancy: A review. Int J Reprod Biomed 2016; 14: 677–686.

[2] Miranda A, Sousa N. Maternal hormonal milieu influence on fetal brain development. Brain Behav 2018; 8: e00920.

[3] Cleary-Goldman J, Malone FD, Lambert-Messerlian G, Sullivan L, Canick J, Porter TF, et al. Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol 2008; 112: 85–92.

[4] Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab 2010; 95: 1699–1707.

[5] Lazarus JH, Bestwick JP, Channon S, Paradice R, Maina A, Rees R, et al. Antenatal thyroid screening and childhood cognitive function. New Eng J Med 2012; 366: 493–501.

[6] Medici M, Korevaar TI, Visser WE, Visser TJ, Peeters RP. Thyroid function in pregnancy: What is normal? Clin Chem 2015; 61: 704–713.

[7] Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt- Rasmussen U, Henry JF, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003; 13: 3–126.

[8] Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou Ch, et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid 2017; 27: 315–389.

[9] World Health Organization. Assessment of iodine deficiency disorders and monitoring their elimination: A guide for programme managers. 3rd Ed. Switzerland: WHO Press; 2007, 1–108.

[10] Naghiaee Y, Lotfi MH, Mozaffari-Khosravi H, Hajimirzadeh M, Amini F, Pirmadah F. Urine iodine status of 8-10-year old school children in Yazd province during ten years (2007– 2016). J Nutr Food Secur 2017; 2: 195–200.

[11] Drover SS, Villanger GD, Aase H, Skogheim TS, Longnecker MP, Zoeller RT, et al. Maternal thyroid function during pregnancy or neonatal thyroid function and attention deficit hyperactivity disorder: A systematic review. Epidemiology 2019; 30: 130–144.

[12] Idris I, Srinivasan R, Simm A, Page RC. Maternal hypothyroidism in early and late gestation: Effects on neonatal and obstetric outcome. Clin Endocrinol 2005; 63: 560–565.

[13] Taylor PN, Zouras S, Min T, Nagarahaj K, Lazarus JH, Okosieme O. Thyroid screening in early pregnancy: Pros and cons. Front Endocrinol 2018; 9: 626.

[14] Mansourian AR, Ahmadi AR, Mansourian HR, Saifi A, Marjani A, Veghari G, et al. Maternal thyroid stimulating hormone level during the first trimester of pregnancy at the south-east of the caspian sea in Iran. J Clin Diagn Res 2010; 4: 2472–2477.

[15] Mehran L, Amouzegar A, Delshad H, Askari S, Hedayati M, Amirshekari G, et al. Trimester-specific reference ranges for thyroid hormones in Iranian pregnant women. J Thyroid Res 2013; 2013: 651517. 1–6.

[16] Marwaha RK, Chopra S, Gopalakrishnan S, Sharma B, Kanwar RS, Sastry A, et al. Establishment of reference range for thyroid hormones in normal pregnant Indian women. BJOG 2008; 115: 602–606.

[17] Dhatt GS, Griffin G, Agarwal MM. Thyroid hormone reference intervals in an ambulatory Arab population on the Abbott Architect i2000 immunoassay analyzer. Clin Chim Acta 2006; 364: 226–229.

[18] Yu B, Wang Qw, Huang RP, Cao F, Zhu ZQ, Sun DC, et al. Establishment of self-sequential longitudinal reference intervals of maternal thyroid function during pregnancy. Exp Biol Med 2010; 235: 1212–1215.

[19] Kianpour M, Aminorroaya A, Amini M, Feizi A, Janghorbani M. Thyroid function test reference ranges in the first trimester of gestation and pregnancy outcomes: Protocol and preliminary results for cohort population-based study Isfahan, Iran. J Res Med Sci 2018; 23: 99.

[20] Soldin O, Hilakivi-Clarke L, Weiderpass E, Soldin S. Trimester-specific reference intervals for thyroxine and triiodothyronine in pregnancy in iodine-sufficient women using isotope dilution tandem mass spectrometry and immunoassays. Clin Chim Acta 2004; 349: 181–189.